Kite, a Gilead Company announced it has leased a new facility in the Netherlands to engineer cell therapies in Europe....
Read moreGilead Sciences, Inc. announced that the U.S. FDA has approved once-daily oral Truvada® (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)—in...
Read moreTeva Pharmaceutical Industries Ltd. announced the publication of data from the Phase III HALO study evaluating the efficacy, safety, and...
Read moreUCB announced positive topline results from C-AXSPAND, a Phase 3 placebo controlled study to investigate the efficacy of CIMZIA® (certolizumab...
Read moreZymeworks Inc. , a clinical-stage biopharmaceutical company developing multifunctional therapeutics, and Daiichi Sankyo Company, Limited announced that they entered into...
Read moreEli Lilly and Company announced that new results from a number of studies across the company's oncology product and pipeline...
Read moreEli Lilly and Company announced that galcanezumab met its primary endpoint in a Phase 3 study of patients with episodic...
Read moreTeva Pharmaceutical Industries Ltd. announced the publication of data from the Phase III HALO study evaluating the efficacy, safety, and...
Read moreHDA’s Pharmaceutical Cargo Security Coalition (PCSC) presented three awards at its educational seminar in East Hanover, New Jersey. Presented annually,...
Read moreNovartis announced the plan to initiate ARROW, a head-to-head proof of concept study to assess the mechanistic superiority of the...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.